Hyperactive mammalian target of rapamycin (mTOR) is associated with cognitive deficits in several neurological disorders including tuberous sclerosis complex (TSC). The phosphorylation of the mRNA-binding protein FMRP reportedly depends on mTOR complex 1 (mTORC1) activity via p70 S6 kinase 1 (S6K1). Because this phosphorylation is thought to regulate the translation of messages important for synaptic plasticity, we explored whether FMRP phosphorylation of the S6K1-dependent residue (S499) is altered in TSC and states of dysregulated TSC-mTORC1 signaling. Surprisingly, we found that FMRP S499 phosphorylation was unchanged in heterozygous and conditional Tsc1 knockout mice despite significantly elevated mTORC1-S6K1 activity. Neither up- nor down-regulation of the mTORC1-S6K1 axis in vivo or in vitro had any effect on phospho-FMRP S499 levels. In addition, FMRP S499 phosphorylation was unaltered in S6K1-knockout mice. Collectively, these data strongly suggest that FMRP S499 phosphorylation is independent of mTORC1-S6K1 activity and is not altered in TSC.
References
[1]
Wang H, Doering LC (2013) Reversing autism by targeting downstream mTOR signaling. Front Cell Neurosci 7: 28.
[2]
Feliciano DM, Hartman NW, Lin TV, Bartley C, Kubera C et al.. (2013) A circuitry and biochemical basis for tuberous sclerosis symptoms: from epilepsy to neurocognitive deficits. Int J Dev Neurosci 667–678.
[3]
Joinson C, O'Callaghan FJ, Osborne JP, Martyn C, Harris T, et al. (2003) Learning disability and epilepsy in an epidemiological sample of individuals with tuberous sclerosis complex. Psychol Med 33: 335–344.
[4]
O'Callaghan FJ, Harris T, Joinson C, Bolton P, Noakes M, et al. (2004) The relation of infantile spasms, tubers, and intelligence in tuberous sclerosis complex. Arch Dis Child 89: 530–533.
[5]
Ehninger D, Han S, Shilyansky C, Zhou Y, Li W, et al. (2008) Reversal of learning deficits in a Tsc2+/？ mouse model of tuberous sclerosis. Nat Med 14: 843–848.
[6]
Auerbach BD, Osterweil EK, Bear MF (2011) Mutations causing syndromic autism define an axis of synaptic pathophysiology. Nature 480: 63–68.
[7]
Goorden SM, van Woerden GM, van der WL, Cheadle JP, Elgersma Y (2007) Cognitive deficits in Tsc1+/？ mice in the absence of cerebral lesions and seizures. Ann Neurol 62: 648–655.
[8]
Potter WB, Basu T, O'Riordan KJ, Kirchner A, Rutecki P, et al. (2013) Reduced juvenile long-term depression in tuberous sclerosis complex is mitigated in adults by compensatory recruitment of mGluR5 and Erk signaling. PLoS Biol 11: e1001627.
[9]
Chevere-Torres I, Kaphzan H, Bhattacharya A, Kang A, Maki JM, et al. (2012) Metabotropic glutamate receptor-dependent long-term depression is impaired due to elevated ERK signaling in the DeltaRG mouse model of tuberous sclerosis complex. Neurobiol Dis 45: 1101–1110. doi: 10.1016/j.nbd.2011.12.028
[10]
Brown V, Jin P, Ceman S, Darnell JC, O'donnell WT, et al. (2001) Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell 107: 477–487.
[11]
Darnell JC, Van Driesche SJ, Zhang C, Hung KY, Mele A, et al. (2011) FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 146: 247–261.
[12]
Ascano M Jr, Mukherjee N, Bandaru P, Miller JB, Nusbaum JD, et al. (2012) FMRP targets distinct mRNA sequence elements to regulate protein expression. Nature 492: 382–386.
[13]
Eberhart DE, Warren ST (1996) The molecular basis of fragile X syndrome. Cold Spring Harb Symp Quant Biol 61: 679–687.
[14]
Sharma A, Hoeffer CA, Takayasu Y, Miyawaki T, McBride SM, et al. (2010) Dysregulation of mTOR signaling in fragile X syndrome. J Neurosci 30: 694–702. doi: 10.1523/jneurosci.3696-09.2010
[15]
Mazroui R, Huot ME, Tremblay S, Boilard N, Labelle Y, et al. (2003) Fragile X Mental Retardation protein determinants required for its association with polyribosomal mRNPs. Hum Mol Genet 12: 3087–3096.
[16]
Ceman S, O'donnell WT, Reed M, Patton S, Pohl J, et al. (2003) Phosphorylation influences the translation state of FMRP-associated polyribosomes. Hum Mol Genet 12: 3295–3305.
[17]
Narayanan U, Nalavadi V, Nakamoto M, Thomas G, Ceman S, et al. (2008) S6K1 phosphorylates and regulates fragile X mental retardation protein (FMRP) with the neuronal protein synthesis-dependent mammalian target of rapamycin (mTOR) signaling cascade. J Biol Chem 283: 18478–18482.
[18]
Ebert DH, Greenberg ME (2013) Activity-dependent neuronal signalling and autism spectrum disorder. Nature 493: 327–337.
[19]
Bassell GJ, Warren ST (2008) Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function. Neuron 60: 201–214.
[20]
Siomi MC, Higashijima K, Ishizuka A, Siomi H (2002) Casein kinase II phosphorylates the fragile X mental retardation protein and modulates its biological properties. Mol Cell Biol 22: 8438–8447.
[21]
Zhang Y, O'Connor JP, Siomi MC, Srinivasan S, Dutra A, et al. (1995) The fragile X mental retardation syndrome protein interacts with novel homologs FXR1 and FXR2. EMBO J 14: 5358–5366.
[22]
Bernard PB, Castano AM, O'Leary H, Simpson K, Browning MD, et al. (2013) Phosphorylation of FMRP and alterations of FMRP complex underlie enhanced mLTD in adult rats triggered by early life seizures. Neurobiol Dis 59: 1–17.
[23]
Evans TL, Mihailescu MR (2010) Recombinant bacterial expression and purification of human fragile X mental retardation protein isoform 1. Protein Expr Purif 74: 242–247.
[24]
Brackett DM, Qing F, Amieux PS, Sellers DL, Horner PJ, et al. (2013) FMR1 transcript isoforms: association with polyribosomes; regional and developmental expression in mouse brain. PLoS ONE 8: e58296.
[25]
Prasad S, Singh K (2008) Age- and sex-dependent differential interaction of nuclear trans-acting factors with Fmr-1 promoter in mice brain. Neurochem Res 33: 1028–1035.
[26]
Singh K, Prasad S (2008) Differential expression of Fmr-1 mRNA and FMRP in female mice brain during aging. Mol Biol Rep 35: 677–684.
[27]
Hallett PJ, Collins TL, Standaert DG, Dunah AW (2008) Biochemical fractionation of brain tissue for studies of receptor distribution and trafficking. Curr Protoc Neurosci Chapter 1: Unit.
[28]
Simeone A, Gulisano M, Acampora D, Stornaiuolo A, Rambaldi M, et al. (1992) Two vertebrate homeobox genes related to the Drosophila empty spiracles gene are expressed in the embryonic cerebral cortex. EMBO J 11: 2541–2550.
[29]
Copp J, Manning G, Hunter T (2009) TORC-specific phosphorylation of mammalian target of rapamycin (mTOR): phospho-Ser2481 is a marker for intact mTOR signaling complex 2. Cancer Res 69: 1821–1827.
[30]
Narayanan U, Nalavadi V, Nakamoto M, Pallas DC, Ceman S, et al. (2007) FMRP phosphorylation reveals an immediate-early signaling pathway triggered by group I mGluR and mediated by PP2A. J Neurosci 27: 14349–14357.
[31]
Pearce LR, Alton GR, Richter DT, Kath JC, Lingardo L, et al. (2010) Characterization of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1). Biochem J 431: 245–255.
[32]
Marmy-Conus N, Hannan KM, Pearson RB (2002) Ro 31–6045, the inactive analogue of the protein kinase C inhibitor Ro 31–8220, blocks in vivo activation of p70(s6k)/p85(s6k): implications for the analysis of S6K signalling. FEBS Lett 519: 135–140.
[33]
Nalavadi VC, Muddashetty RS, Gross C, Bassell GJ (2012) Dephosphorylation-induced ubiquitination and degradation of FMRP in dendrites: a role in immediate early mGluR-stimulated translation. J Neurosci 32: 2582–2587.
[34]
Feliciano DM, Su T, Lopez J, Platel JC, Bordey A (2011) Single-cell Tsc1 knockout during corticogenesis generates tuber-like lesions and reduces seizure threshold in mice. J Clin Invest 121: 1596–1607.
[35]
Pende M, Um SH, Mieulet V, Sticker M, Goss VL, et al. (2004) S6K1(？/？)/S6K2(？/？) mice exhibit perinatal lethality and rapamycin-sensitive 5'-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway. Mol Cell Biol 24: 3112–3124.
[36]
Cheever A, Ceman S (2009) Phosphorylation of FMRP inhibits association with Dicer. RNA 15: 362–366. doi: 10.1261/rna.1500809
[37]
Wang H, Morishita Y, Miura D, Naranjo JR, Kida S, et al. (2012) Roles of CREB in the regulation of FMRP by group I metabotropic glutamate receptors in cingulate cortex. Mol Brain 5: 27.
[38]
Zhao W, Chuang SC, Bianchi R, Wong RK (2011) Dual regulation of fragile X mental retardation protein by group I metabotropic glutamate receptors controls translation-dependent epileptogenesis in the hippocampus. J Neurosci 31: 725–734.
[39]
Iliff AJ, Renoux AJ, Krans A, Usdin K, Sutton MA, et al. (2013) Impaired activity-dependent FMRP translation and enhanced mGluR-dependent LTD in Fragile X premutation mice. Hum Mol Genet 22: 1180–1192.
Hou L, Antion MD, Hu D, Spencer CM, Paylor R, et al. (2006) Dynamic translational and proteasomal regulation of fragile X mental retardation protein controls mGluR-dependent long-term depression. Neuron 51: 441–454.
[42]
Ruvinsky I, Meyuhas O (2006) Ribosomal protein S6 phosphorylation: from protein synthesis to cell size. Trends Biochem Sci 31: 342–348.
[43]
Meyuhas O, Dreazen A (2009) Ribosomal protein S6 kinase from TOP mRNAs to cell size. Prog Mol Biol Transl Sci 90: 109–153.
[44]
Hornbeck PV, Kornhauser JM, Tkachev S, Zhang B, Skrzypek E, et al. (2012) PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse. Nucleic Acids Res 40: D261–D270.
[45]
Coffee RL Jr, Williamson AJ, Adkins CM, Gray MC, Page TL, et al. (2012) In vivo neuronal function of the fragile X mental retardation protein is regulated by phosphorylation. Hum Mol Genet 21: 900–915.
[46]
Siomi MC, Higashijima K, Ishizuka A, Siomi H (2002) Casein kinase II phosphorylates the fragile X mental retardation protein and modulates its biological properties. Mol Cell Biol 22: 8438–8447.
[47]
Kang A, Hoeffer CA, Arnold EC, Cziko A-M, Ramaswami M et al.. (2008) Casein kinase inhibitors block fragile X mental retardation protein binding with fragile X mental retardation autosomal homolog 1. Neuroscience meeting planner Washington, DC: Society for Neuroscience 38.20.
[48]
Villasana LE, Klann E, Tejada-Simon MV (2006) Rapid isolation of synaptoneurosomes and postsynaptic densities from adult mouse hippocampus. J Neurosci Methods 158: 30–36. doi: 10.1016/j.jneumeth.2006.05.008
[49]
Maehama T, Tanaka M, Nishina H, Murakami M, Kanaho Y, et al. (2008) RalA functions as an indispensable signal mediator for the nutrient-sensing system. J Biol Chem 283: 35053–35059.
[50]
Pasumarthi KB, Nakajima H, Nakajima HO, Jing S, Field LJ (2000) Enhanced cardiomyocyte DNA synthesis during myocardial hypertrophy in mice expressing a modified TSC2 transgene. Circ Res 86: 1069–1077.
[51]
Urano J, Sato T, Matsuo T, Otsubo Y, Yamamoto M, et al. (2007) Point mutations in TOR confer Rheb-independent growth in fission yeast and nutrient-independent mammalian TOR signaling in mammalian cells. Proc Natl Acad Sci U S A 104: 3514–3519.
